145 related articles for article (PubMed ID: 30922767)
1. Methiopropamine, a methamphetamine analogue, produces neurotoxicity via dopamine receptors.
Nguyen PT; Dang DK; Tran HQ; Shin EJ; Jeong JH; Nah SY; Cho MC; Lee YS; Jang CG; Kim HC
Chem Biol Interact; 2019 May; 305():134-147. PubMed ID: 30922767
[TBL] [Abstract][Full Text] [Related]
2. Role of dopamine D1 receptor in 3-fluoromethamphetamine-induced neurotoxicity in mice.
Nguyen PT; Shin EJ; Dang DK; Tran HQ; Jang CG; Jeong JH; Lee YJ; Lee HJ; Lee YS; Yamada K; Nabeshima T; Kim HC
Neurochem Int; 2018 Feb; 113():69-84. PubMed ID: 29197543
[TBL] [Abstract][Full Text] [Related]
3. Genetic or pharmacological depletion of cannabinoid CB1 receptor protects against dopaminergic neurotoxicity induced by methamphetamine in mice.
Dang DK; Shin EJ; Mai AT; Jang CG; Nah SY; Jeong JH; Ledent C; Yamamoto T; Nabeshima T; Onaivi ES; Kim HC
Free Radic Biol Med; 2017 Jul; 108():204-224. PubMed ID: 28363605
[TBL] [Abstract][Full Text] [Related]
4. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
Gross NB; Duncker PC; Marshall JF
Synapse; 2011 Nov; 65(11):1144-55. PubMed ID: 21584865
[TBL] [Abstract][Full Text] [Related]
5. Effects of intrastriatal dopamine D1 or D2 antagonists on methamphetamine-induced egocentric and allocentric learning and memory deficits in Sprague-Dawley rats.
Gutierrez A; Regan SL; Hoover CS; Williams MT; Vorhees CV
Psychopharmacology (Berl); 2019 Jul; 236(7):2243-2258. PubMed ID: 30919007
[TBL] [Abstract][Full Text] [Related]
6. The role of system Xc
Dang DK; Shin EJ; Tran HQ; Kim DJ; Jeong JH; Jang CG; Nah SY; Sato H; Nabeshima T; Yoneda Y; Kim HC
Neurochem Int; 2017 Sep; 108():254-265. PubMed ID: 28457879
[TBL] [Abstract][Full Text] [Related]
7. The expression of methiopropamine-induced locomotor sensitization requires dopamine D2, but not D1, receptor activation in the rat.
Yoon HS; Cai WT; Lee YH; Park KT; Lee YS; Kim JH
Behav Brain Res; 2016 Sep; 311():403-407. PubMed ID: 27265782
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
[TBL] [Abstract][Full Text] [Related]
9. Antagonists of the neurokinin-1 or dopamine D1 receptors confer protection from methamphetamine on dopamine terminals of the mouse striatum.
Angulo JA; Angulo N; Yu J
Ann N Y Acad Sci; 2004 Oct; 1025():171-80. PubMed ID: 15542715
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2.
Ramkissoon A; Wells PG
Free Radic Biol Med; 2015 Dec; 89():358-68. PubMed ID: 26427884
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor.
Dang DK; Shin EJ; Kim DJ; Tran HQ; Jeong JH; Jang CG; Nah SY; Jeong JH; Byun JK; Ko SK; Bing G; Hong JS; Kim HC
J Neuroinflammation; 2018 Feb; 15(1):52. PubMed ID: 29467000
[TBL] [Abstract][Full Text] [Related]
12. Apocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERK.
Dang DK; Shin EJ; Nam Y; Ryoo S; Jeong JH; Jang CG; Nabeshima T; Hong JS; Kim HC
J Neuroinflammation; 2016 Jan; 13():12. PubMed ID: 26780950
[TBL] [Abstract][Full Text] [Related]
13. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems.
Sonsalla PK; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1986 Sep; 238(3):932-7. PubMed ID: 2943891
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological assessment of methamphetamine-induced behavioral hyperactivity mediated by dopaminergic transmission in planarian Dugesia japonica.
Tashiro N; Nishimura K; Daido K; Oka T; Todo M; Toshikawa A; Tsushima J; Takata K; Ashihara E; Yoshimoto K; Agata K; Kitamura Y
Biochem Biophys Res Commun; 2014 Jul; 449(4):412-8. PubMed ID: 24858686
[TBL] [Abstract][Full Text] [Related]
15. Protective and restorative effects of the traditional Chinese medicine Jitai tablet against methamphetamine-induced dopaminergic neurotoxicity.
Xu S; Tu S; Gao J; Liu J; Guo Z; Zhang J; Liu X; Liang J; Huang Y; Han M
BMC Complement Altern Med; 2018 Feb; 18(1):76. PubMed ID: 29475448
[TBL] [Abstract][Full Text] [Related]
16. Exposure to Far Infrared Ray Protects Methamphetamine-Induced Behavioral Sensitization in Glutathione Peroxidase-1 Knockout Mice via Attenuating Mitochondrial Burdens and Dopamine D1 Receptor Activation.
Mai HN; Sharma N; Shin EJ; Nguyen BT; Jeong JH; Jang CG; Cho EH; Nah SY; Kim NH; Nabeshima T; Kim HC
Neurochem Res; 2018 May; 43(5):1118-1135. PubMed ID: 29687308
[TBL] [Abstract][Full Text] [Related]
17. The new designer drug buphedrone produces rewarding properties via dopamine D1 receptor activation.
Oh JH; Hwang JY; Hong SI; Ma SX; Seo JY; Lee SY; Kim HC; Jang CG
Addict Biol; 2018 Jan; 23(1):69-79. PubMed ID: 27790823
[TBL] [Abstract][Full Text] [Related]
18. The role of dopamine receptors in the neurotoxicity of methamphetamine.
Ares-Santos S; Granado N; Moratalla R
J Intern Med; 2013 May; 273(5):437-53. PubMed ID: 23600399
[TBL] [Abstract][Full Text] [Related]
19. A role for D1 dopamine receptors in striatal methamphetamine-induced neurotoxicity.
Friend DM; Keefe KA
Neurosci Lett; 2013 Oct; 555():243-7. PubMed ID: 23994061
[TBL] [Abstract][Full Text] [Related]
20. Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors.
Xu W; Zhu JP; Angulo JA
Synapse; 2005 Nov; 58(2):110-21. PubMed ID: 16088948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
